БАЗА МЕДИЦИНСКИХ ЗНАНИЙ

Summary of National Advisory Committee on Immunization statement of March 2023: Interim guidance on the use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations

National Advisory Committee on ImmunizationВакцинация2023Официальная публикация

Документальный обзор ASEM

Official National Advisory Committee on Immunization document (2023) on “Summary of National Advisory Committee on Immunization statement of March 2023: Interim guidance on the use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations”. Summary of NACI guidance on safety and recommended use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations in Canada.

Это краткое содержание помогает найти нужный документ. В отношении клинических рекомендаций всегда сверяйтесь с официальной версией и датой её обновления.

Официальный документ

По той же теме

Summary of NACI statement of May 2026: Statement on seasonal influenza vaccines for 2026-2027 Summary of NACI statement of June 2026: Guidance on the use of COVID-19 vaccines starting fall 2026 Summary of updates in the Canadian Immunization Guide as of March 31, 2025: Updated guidance on quadrivalent conjugate meningococcal vaccines available in Canada